IFNB1 and myeloid sarcoma: No MS treatment or treated with beta-interferon (Avonex, Rebif, Betaseron), Tysabri, Fingolimod, Tecfidera, Aubagio, Lemtrada, corticosteroids, or other immunosuppressive or immunomodulatory therapy in the previous 3 months